Mets B, Frumento R J, Bennett-Guerrero E, Naka Y
Department of Anesthesiology, Columbia University, New York, NY, USA.
J Cardiothorac Vasc Anesth. 2002 Dec;16(6):727-30. doi: 10.1053/jcan.2002.128411.
To assess the accuracy of a continuous cardiac output (CCO) monitor against an independent, intravascular measurement of flow as can be performed in patients fitted with a left ventricular assist device (LVAD).
A prospective cohort study.
Academic tertiary-care center.
Adult patients (n = 15) presenting for LVAD placement.
Consenting patients presenting for LVAD placement for end-stage cardiac failure were anesthetized, and a CCO pulmonary artery catheter was placed (OptiQ, CCO/SvO(2); Abbott Critical Care, North Chicago, IL). Patients were monitored with transesophageal echocardiography and excluded from analysis if aortic regurgitation was found. Cardiac output was determined using a Q-Vue, CCO/SvO(2) computer with digital readout (Abbott Critical Care, North Chicago, IL). The LVAD was placed in standard fashion during cardiopulmonary bypass. The Thoratec vented electric Heartmate (Thoratec Co, Pleasanton, CA) incorporates an LVAD flow console, which computes LVAD flow within +/- 5% (range, 1.8 to 10 L/min).
Cardiac output flow measurements were made from both systems at the following time points: 5 minutes and 30 minutes after protamine administration, at chest closure, and after skin closure. Mean cardiac output for each device did not differ at any time point. Regression analysis (Pearson's) showed acceptable correlation (r(2) = 0.79, p < 0.0001), whereas a bias of 529 mL with limits of agreement of 1,208 mL were shown for CCO measurement compared with LVAD flow.
The data indicate that the CCO system tends to overestimate cardiac output by approximately 500 mL/min when compared with LVAD flow. Nevertheless, this bias is within the range found by other less-invasive studies done to assess the accuracy of this system and further serves to confirm its relative accuracy.
针对可在植入左心室辅助装置(LVAD)的患者中进行的独立血管内血流测量,评估连续心输出量(CCO)监测仪的准确性。
前瞻性队列研究。
学术性三级医疗中心。
准备接受LVAD植入的成年患者(n = 15)。
因终末期心力衰竭而准备接受LVAD植入的同意患者接受麻醉,并置入一根CCO肺动脉导管(OptiQ,CCO/SvO₂;雅培重症监护,伊利诺伊州北芝加哥)。通过经食管超声心动图对患者进行监测,若发现主动脉瓣反流则排除在分析之外。使用带有数字读数的Q-Vue、CCO/SvO₂计算机(雅培重症监护,伊利诺伊州北芝加哥)测定心输出量。在体外循环期间以标准方式植入LVAD。Thoratec排气式电动Heartmate(Thoratec公司,加利福尼亚州普莱森顿)包含一个LVAD流量控制台,该控制台计算出的LVAD流量误差在±5%以内(范围为1.8至10 L/分钟)。
在以下时间点从两个系统进行心输出量测量:注射鱼精蛋白后5分钟和30分钟、关胸时以及皮肤缝合后。在任何时间点,每个装置的平均心输出量均无差异。回归分析(Pearson检验)显示出可接受的相关性(r² = 0.79,p < 0.0001),而与LVAD流量相比,CCO测量显示偏差为529 mL,一致性界限为1208 mL。
数据表明,与LVAD流量相比,CCO系统倾向于将心输出量高估约500 mL/分钟。然而,该偏差在其他为评估该系统准确性而进行的侵入性较小的研究中所发现的范围内,进一步证实了其相对准确性。